BIOTECHNOLOGY VALUE FUND L P

SAN FRANCISCO, CA Hedge Fund How do I update this listing?

Biotechnology Value Fund L P is based out of San Francisco. Whalewisdom has at least 113 13D filings, 594 13G filings, and 5 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2021-01-07. The filing was for a pooled investment fund: hedge fund The notice included securities offered of Pooled Investment Fund Interests

Create Alert

Contact Info

biotechnology value fund l p
44 MONTGOMERY STREET
SAN FRANCISCO CA    94104

Business Phone: 3125066500
SEC SIC CODE:
6282-INVESTMENT ADVICE
Current 13D/G Holdings
Stock Sector Shares Held Market Value Rank Source Source Date
Principia Biopharma Inc (PRNB) HEALTH CARE 5,231,900 523,451,595.00 1 13D 2020-08-25
Olema Pharmaceuticals, Inc. (OLMA) HEALTH CARE 6,661,503 320,285,064.24 2 13D 2020-11-19
Calliditas Therapeutics AB ADS (CALT) HEALTH CARE 7,431,562 249,849,114.44 3 13G 2020-11-09
Five Prime Therapeutics Inc (FPRX) HEALTH CARE 6,338,678 240,869,764.00 4 13G 2021-03-04
Kymera Therapeutics, Inc. (KYMR) HEALTH CARE 2,630,662 163,101,044.00 5 13D 2020-08-21
Xoma Corporation (XOMA) HEALTH CARE 3,530,543 144,081,459.83 6 13D 2021-03-31
Inventiva S.A. ADR (IVA) HEALTH CARE 7,958,138 115,393,001.00 7 13D 2020-07-10
Repare Therapeutics Inc. (RPTX) HEALTH CARE 3,722,398 103,296,544.50 8 13G 2021-03-12
Merus BV (MRUS) HEALTH CARE 5,805,571 101,771,659.63 9 13G 2020-12-31
First Eagle Credit Opportunities Fund-Class A (FECAX) 1,750,000 86,642,500.00 10 13G 2017-04-13
Protagonist Therapeutics Inc (PTGX) HEALTH CARE 4,274,965 86,183,294.40 11 13G 2020-12-31
Syndax Pharmaceuticals Inc (SNDX) HEALTH CARE 3,710,689 82,525,723.36 12 13G 2020-12-31
Forward Pharma A/S ADR (FWP) HEALTH CARE 10,194,786 71,669,345.58 13 13G 2020-12-31
Cascadian Therapeutics, Inc. (CASC) HEALTH CARE 6,008,224 60,202,404.48 14 13G 2017-02-02
CTI BioPharma Corp (CTIC) HEALTH CARE 17,123,023 56,505,975.90 15 13D 2021-03-10
Xenon Pharmaceuticals Inc (XENE) HEALTH CARE 3,499,346 53,819,941.48 16 13G 2020-12-31
Spero Therapeutics Inc (SPRO) HEALTH CARE 2,768,278 53,676,910.42 17 13G 2020-12-31
Realm Therapeutics PLC (RLM) HEALTH CARE 21,451,171 53,627,927.50 18 13G 2018-12-31
Ikena Oncology Inc (IKNA) 1,599,658 51,189,056.00 19 13G 2021-03-26
Forte Biosciences Inc. (Tocagen) (TOCA) HEALTH CARE 1,344,262 48,944,579.42 20 13G 2020-12-31
AC Immune SA (ACIU) HEALTH CARE 7,916,658 48,054,114.06 21 13G 2021-01-12
Ideaya Biosciences Inc (IDYA) HEALTH CARE 3,226,769 45,174,766.00 22 13G 2020-12-31
Essa Pharma Inc (EPIX) HEALTH CARE 3,705,289 44,204,097.77 23 13G 2020-12-31
Lexicon Pharmaceuticals Inc (LXRX) HEALTH CARE 10,963,000 37,493,460.00 24 13G 2020-12-11
CytomX Therapeutics Inc (CTMX) HEALTH CARE 5,576,471 36,525,885.05 25 13G 2020-12-31
GlycoMimetics Inc (GLYC) HEALTH CARE 9,544,262 35,886,425.12 26 13G 2020-12-31
Erytech Pharma SA ADR (ERYP) HEALTH CARE 4,081,941 32,802,477.88 27 13G 2021-03-08
Infinity Pharmaceuticals Inc (INFI) HEALTH CARE 8,383,645 31,941,687.45 28 13G 2021-02-17
Molecular Templates Inc (MTEM) HEALTH CARE 2,761,121 25,926,926.19 29 13G 2020-12-31
Ovid Therapeutics Inc (OVID) HEALTH CARE 6,631,051 24,269,646.66 30 13G 2021-04-13
Verastem Inc (VSTM) HEALTH CARE 11,180,994 23,815,517.22 31 13G 2020-12-31
Eledon Pharmaceuticals Inc (ELDN) HEALTH CARE 1,503,121 23,148,063.40 32 13G 2020-12-31
Calithera Biosciences Inc (CALA) HEALTH CARE 4,361,238 21,413,678.58 33 13G 2020-12-31
ContraFect Corp (CFRX) HEALTH CARE 3,972,300 15,690,585.00 34 13G 2021-04-13
Selecta Biosciences Inc (SELB) HEALTH CARE 4,926,108 14,926,107.24 35 13G 2019-12-23
Alpine Immune Sciences Inc (ALPN) HEALTH CARE 1,137,764 14,335,826.40 36 13G 2019-12-31
Pieris Pharmaceuticals Inc (PIRS) HEALTH CARE 5,601,582 14,003,955.00 37 13G 2020-12-31
Therapeutics Acquisition Corp (RACA) FINANCE 954,996 13,293,544.32 38 13G 2020-12-31
Genocea Biosciences Inc (GNCA) HEALTH CARE 5,285,549 12,791,028.58 39 13G 2020-12-31
Gritstone Oncology Inc (GRTS) HEALTH CARE 2,695,418 10,619,946.92 40 13G 2020-12-30
Corvus Pharmaceuticals Inc (CRVS) HEALTH CARE 2,898,797 10,319,717.32 41 13G 2020-12-31
Regulus Therapeutics Inc (RGLS) HEALTH CARE 7,050,464 9,518,126.40 42 13G 2020-12-31
Cidara Therapeutics Inc (CDTX) HEALTH CARE 4,461,494 8,922,988.00 43 13G 2020-12-31
Regado BioSciences, Inc. (TBRA) HEALTH CARE 209,148 8,803,923.21 44 13G 2014-12-31
Viridian Therapeutics Inc (VRDN) HEALTH CARE 505,867 8,321,518.89 45 13G 2020-10-28
Aileron Therapeutics Inc (ALRN) HEALTH CARE 5,265,555 6,476,632.65 46 13G 2021-01-06
Galmed Pharmaceuticals Ltd (GLMD) HEALTH CARE 1,799,694 5,597,048.34 47 13G 2020-12-31
5:01 Acquisition Corp. (FVAM) FINANCE 500,000 5,085,000.00 48 13G 2020-10-14
Sunesis Pharmaceuticals Inc (VIRX) HEALTH CARE 1,814,308 3,610,472.92 49 13G 2020-12-31
GlobeImmune Inc (GBIM) HEALTH CARE 657,653 157,836.72 50 13G 2015-12-31
Aeolus Pharmaceutical (AOLS) HEALTH CARE 15,213,480 152,134.80 51 13G 2015-12-31
Anthera Pharmaceuticals Inc (ANTH) HEALTH CARE 1,658,157 33,163.14 52 13G 2017-12-31
Orexigen Therapeutics Inc (OREXQ) HEALTH CARE 2,036,860 20,368.60 53 13G 2018-12-31
X4 PHARMACEUTICALS ORD SHS (XFOR) 1,719,616 54 13G 2020-12-31

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2021-01-07 D/A POOLED INVESTMENT FUND: HEDGE FUND Pooled Investment Fund Interests INDEFINITE 675,082,682 INDEFINITE
2020-01-10 D/A POOLED INVESTMENT FUND: HEDGE FUND Pooled Investment Fund Interests INDEFINITE 413,832,682 INDEFINITE
2019-01-11 D/A POOLED INVESTMENT FUND: HEDGE FUND Pooled Investment Fund Interests INDEFINITE 224,032,682 INDEFINITE
2017-12-08 D/A POOLED INVESTMENT FUND: HEDGE FUND Pooled Investment Fund Interests INDEFINITE 224,032,682 INDEFINITE
2016-09-21 D/A POOLED INVESTMENT FUND: HEDGE FUND Pooled Investment Fund Interests INDEFINITE 212,032,682 INDEFINITE
2014-11-12 D/A POOLED INVESTMENT FUND: HEDGE FUND Pooled Investment Fund Interests INDEFINITE 64,755,500 INDEFINITE
2013-11-08 D/A POOLED INVESTMENT FUND: HEDGE FUND Pooled Investment Fund Interests INDEFINITE 41,655,500 INDEFINITE
2012-11-08 D/A POOLED INVESTMENT FUND: HEDGE FUND Pooled Investment Fund Interests INDEFINITE 37,655,500 INDEFINITE
2011-11-08 D/A POOLED INVESTMENT FUND: HEDGE FUND Pooled Investment Fund Interests INDEFINITE 36,155,500 INDEFINITE
2010-10-21 D POOLED INVESTMENT FUND: HEDGE FUND Pooled Investment Fund Interests INDEFINITE 34,905,500 INDEFINITE
2009-10-15 D/A POOLED INVESTMENT FUND: HEDGE FUND Pooled Investment Fund Interests INDEFINITE 29,155,500 INDEFINITE
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
JAMES KRATKY subscription required
    EXECUTIVE OFFICER
JASON MCCUNE subscription required
    EXECUTIVE OFFICER
MARC N. LAMPERT subscription required
    EXECUTIVE OFFICER
MARK N LAMPERT subscription required
    EXECUTIVE OFFICER
MATTHEW D PERRY subscription required
    EXECUTIVE OFFICER
MITCHELL KAYE subscription required
    EXECUTIVE OFFICER
N/A BVF GP HOLDINGS LLC subscription required
    EXECUTIVE OFFICER
N/A BVF I GP LLC subscription required
    EXECUTIVE OFFICER
N/A BVF INC. subscription required
    EXECUTIVE OFFICER
N/A BVF PARTNERS, L.P. subscription required
    EXECUTIVE OFFICER
OLEG NODELMAN subscription required
    EXECUTIVE OFFICER
SPIKE LOY subscription required
    EXECUTIVE OFFICER

Elevate your investments